With biotech stocks in the dumps, investors have been hoping for deals to revive the sector, but lately merger-and-acquisition activity has been anemic. Finally, Pfizer announced it will buy Biohaven Pharmaceutical Holding Company Ltd, a nine-year-old company that makes treatments for migraines, for $11.6 billion. The deal, which gives Pfizer an oral drug already on the market and a nasal ...

  Without much fanfare, some of the biggest names in tech have been pulling back on once-enthusiastic efforts to disrupt healthcare. Within the past nine months, Alphabet Inc has dismantled its healthcare division Google Health while IBM sold its Watson Health data and analytics business to a private equity firm, having struggled to turn a profit. It turns out healthcare ...

  Americans are reminded about high gasoline prices daily, every time they drive. Another energy cost comes to their attention monthly: utility bills. These are now also rising, creating an added problem for households, for the president — and, as it happens, for utilities. Governor Ron DeSantis of Florida recently threw a curveball when he vetoed utility-friendly solar power legislation. ...